Memic Announces Adoption of Hominis® Surgical System at Three U.S. Hospitals
9 January, 2022
HCA Florida Healthcare’s Kendall Regional Medical Center, AdventHealth Celebration and The Women’s Hospital at Jackson Memorial have aquired Memic's robot for use in transvaginal gynecological procedures
Memic Innovative Surgery Ltd. (Memic), a medical device company dedicated to transforming surgery with its proprietary surgical robotic technology, today announced that HCA Florida Healthcare’s Kendall Regional Medical Center, AdventHealth Celebration and The Women’s Hospital at Jackson Memorial have acquired the Hominis® Surgical System for use in single site, natural orifice laparoscopic-assisted transvaginal benign gynecological procedures including benign hysterectomy. Hominis is the first and only FDA-authorized surgical robot that features miniature humanoid-shaped arms, with shoulder, elbow, and wrist joints that provide human level dexterity and 360-degree articulation.
“It is essential that healthcare systems and clinicians continue to invest in innovative and disruptive technology to offer superior healthcare and optimal outcomes for patients,” said Ricardo E. Estape, MD, a practicing gynecology oncologist at Kendall Regional Medical Center and director of HCA Healthcare’s Institute for Gynecologic Oncology. “Kendall is one of the busiest robotic surgery programs in South Florida, and we are proud to be among the first in the U.S. to offer this novel system, allowing us to perform minimally invasive gynecological procedures using the transvaginal approach, which is known to offer less pain, lower infection rates, faster recovery, and no visible scarring.”
The Hominis System is designed to replicate the motions and capabilities of a surgeon’s arms. Multiple instruments can be introduced to the body through a single portal and the 360-degree articulation offers obstacle avoidance as well as optimal access and working angles. Hominis requires a much smaller footprint and costs significantly less than conventional robotic systems, making it possible for more hospitals and ambulatory surgery centers to acquire the system and offer more patients the benefits of less invasive robotic surgery. Hominis was granted de novo marketing authorization from the FDA in February 2021.
“As a leader in robotic surgery, we are always looking to bring innovative and leading edge technology to our community to enhance efficiency with surgical techniques and highlight our overall commitment to whole person health care. This technology will allow us to perform surgical techniques not feasible today and improve the surgical experience for a wide range of patients,” said Doug Harcombe, CEO at AdventHealth Celebration.
“As one of the region’s most cutting-edge surgical centers, we are excited to be adding new technology and surgical solutions that will benefit our patients,” said Joanne Ruggiero, MSN, MA, NE-BC, interim CEO of Holtz Children’s Hospital/The Women’s Hospital at Jackson Memorial. “We are proud to be among the first in the country to offer this new scarless surgery, and look forward to making an impact in the lives of our South Florida patients.”
“We are proud to partner with these leading healthcare providers to empower surgeons with a better user experience and help them better serve the thousands of women who undergo gynecologic surgery each year,” said Dvir Cohen, co-founder and chief executive officer of Memic. “These sites establish a strong foundation for expanding market adoption of Hominis, including a leading robotic surgery center of excellence, a 450-bed hospital owned by one of the largest U.S. hospital systems, and a 1,550-bed nonprofit teaching hospital affiliated with an acclaimed medical school. With their support, we are expanding our commercial footprint to increase the reach of our proprietary technology and have a positive impact on the Florida region and elsewhere as we work to expand adoption of Hominis worldwide.”
Posted in tags: Memic , Surgical Robotics